Cart 0

MarketsandMarkets

Digital Therapeutics Market - Global Forecast to 2021 Market Research Report

$5,650.00

Report Published By: MarketsandMarkets
Publication Date : Jul-16
No. Of Pages: 187

The digital therapeutics market in terms of value is expected to reach USD 457.9 million by 2021 from USD 110 million in 2016, growing at a CAGR of 27.7% from 2016 to 2021. This market is categorized on the basis of application, sales channel, and region.
Major factors contributing to the growth of the digital therapeutics market include increasing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics. Government initiatives to support the development and adoption of digital therapeutics solutions also provide an impetus for the growth of this market. For instance, in 2010, the U.S. Congress authorized the Centers for Disease Control and Prevention (CDC) to create the Diabetes Prevention Recognition Program (DPRP) and recognize programs that meet evidence-based standards provided by DPRP. This includes programs such as the “Prevent” program offered by Omada Health Inc. (U.S.) implemented for the prevention of diabetes. Additionally, the Affordable Care Act (2010) authorized a series of diabetes prevention programs under the National Diabetes Prevention Program (NDPP). One example of such a program is three digital diabetes prevention programs, provided by Canary Health (U.S.), Noom Health (U.S.), and Omada Health (U.S.), which received recognition in 2015. Such government initiatives are likely to provide an impetus for market growth. Relatively untapped markets in developing regions of Asia-Pacific and unexplored therapeutic applications have opened an array of opportunities for the digital therapeutics market. However, factors such as a lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the growth of this market.
Apart from the comprehensive geographical and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the digital therapeutics market and their product portfolios, developments, and strategies. The above-mentioned market research data, current market size, and forecast of the future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.






Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of top players in the digital therapeutics market. The report analyzes the digital therapeutics market by application, sales channel, and region
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the digital therapeutics market
• Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the digital therapeutics market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various digital therapeutics products across geographies
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the digital therapeutics market

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 20
1.5 LIMITATIONS 20
1.6 MARKET STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 MARKET SIZE ESTIMATION 22
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.3 KEY DATA FROM SECONDARY SOURCES 26
2.4 KEY DATA FROM PRIMARY SOURCES 26
2.5 KEY INDUSTRY INSIGHTS 27
2.6 ASSUMPTIONS FOR THE STUDY 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 35
4.1 DIGITAL THERAPEUTICS MARKET OVERVIEW 35
4.2 DIGITAL THERAPEUTICS MARKET, BY APPLICATION 36
4.3 DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS 36
4.4 DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE APPLICATIONS 37
4.5 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL 37
4.6 DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER 38
4.7 DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER 39
4.8 DIGITAL THERAPEUTICS MARKET: GEOGRAPHIC SNAPSHOT 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 Increasing incidence of preventable chronic diseases 43
5.2.1.2 Rising focus on preventive healthcare 43
5.2.1.3 Technological advancements 44
5.2.1.4 Need to control healthcare costs 44
5.2.1.5 Significant increase in venture capital investments 45
5.2.1.6 Benefits offered by digital therapeutics 45
5.2.1.6.1 Ability to induce behavioral change 45
5.2.1.6.2 Improved drug adherence 46
5.2.1.6.3 Patient convenience and user-friendliness 46
5.2.2 RESTRAINTS 47
5.2.2.1 Lack of awareness and access to digital therapeutics programs in developing countries 47
5.2.2.2 Patient data privacy concerns 47
5.2.2.3 Resistance from traditional healthcare providers 47
5.2.3 OPPORTUNITIES 48
5.2.3.1 Emerging markets offer significant growth opportunities 48
5.2.3.2 Large undiagnosed and untreated population 49
5.2.3.3 Unexplored therapeutic applications 49
5.2.4 CHALLENGES 50
5.2.4.1 Unfavorable payment models 50
5.2.4.2 Stringent regulatory guidelines 50
5.2.4.3 Reluctance among patients to adopt digital therapeutics 51
6 INDUSTRY INSIGHTS 52
6.1 INTRODUCTION 53
6.2 PORTER’S FIVE FORCES ANALYSIS 53
6.2.1 THREAT OF NEW ENTRANTS 54
6.2.2 BARGAINING POWER OF SUPPLIERS 54
6.2.3 BARGAINING POWER OF BUYERS 54
6.2.4 THREAT OF SUBSTITUTES 55
6.2.5 INTENSITY OF COMPETITIVE RIVALRY 55
6.3 REGULATORY REQUIREMENTS 55
6.3.1 EMERGING REGULATORY FRAMEWORK FOR DIGITAL THERAPEUTICS 55
6.3.2 HEALTH INFORMATION PORTABILITY AND ACCOUNTABILITY ACT (HIPAA) 56
6.4 VENTURE CAPITAL INVESTMENTS 56
6.5 PIPELINE PRODUCTS 58
7 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL 60
7.1 INTRODUCTION 61
7.2 B2C 62
7.2.1 CAREGIVERS 65
7.2.2 PATIENTS 66
7.3 B2B 69
7.3.1 PROVIDERS 72
7.3.2 PAYERS 74
7.3.3 PHARMACEUTICAL COMPANIES 76
7.3.4 EMPLOYERS 77
7.3.5 OTHER BUYERS 79
8 DIGITAL THERAPEUTICS MARKET, BY TYPE OF APPLICATION 81
8.1 INTRODUCTION 82
8.2 PREVENTIVE APPLICATIONS 84
8.2.1 PREDIABETES 87
8.2.2 OBESITY 89
8.3 TREATMENT/CARE-RELATED APPLICATIONS 91
8.3.1 DIABETES 94
8.3.2 CENTRAL NERVOUS SYSTEM (CNS) DISORDERS 96
8.3.3 CHRONIC RESPIRATORY DISEASES (CRD) 98
8.3.4 MUSCULOSKELETAL DISORDERS 100
8.3.5 CARDIOVASCULAR DISEASES 102
8.3.6 SMOKING CESSATION 104
8.3.7 MEDICATION ADHERENCE 106
8.3.8 OTHER APPLICATIONS 108
9 DIGITAL THERAPEUTICS MARKET, BY REGION 110
9.1 INTRODUCTION 111
9.2 NORTH AMERICA 113
9.2.1 U.S. 118
9.2.2 CANADA 122
9.3 EUROPE 126
9.3.1 GERMANY 130
9.3.2 U.K. 133
9.3.3 FRANCE 136
9.3.4 SPAIN 139
9.3.5 REST OF EUROPE (ROE) 142
9.4 ASIA-PACIFIC (APAC) 145
9.5 REST OF THE WORLD (ROW) 149
10 COMPETITIVE LANDSCAPE 152
10.1 OVERVIEW 152
10.2 COMPETITIVE SITUATIONS AND TRENDS 155
10.2.1 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS 156
10.2.2 INVESTMENTS 157
10.2.3 NEW PRODUCT LAUNCHES 158
10.2.4 OTHER STRATEGIES 159
?
11 COMPANY PROFILES 160
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 INTRODUCTION 160
11.2 PROTEUS DIGITAL HEALTH, INC. 161
11.3 OMADA HEALTH, INC. 163
11.4 WELLDOC, INC. 165
11.5 LIVONGO HEALTH 167
11.6 NOOM INC. 169
11.7 GINGER.IO, INC. 171
11.8 PROPELLER HEALTH 172
11.9 2MORROW INC. 173
11.10 CANARY HEALTH INC. 174
11.11 MANGO HEALTH INC. 175

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX 176
12.1 INSIGHTS FROM INDUSTRY EXPERTS 176
12.2 DISCUSSION GUIDE 177
12.3 OTHER DEVELOPMENTS, BY COMPANY, 2013–2016 180
12.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 183
12.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 185
12.6 AVAILABLE CUSTOMIZATIONS 185
12.7 RELATED REPORTS 186
LIST OF TABLES

TABLE 1 INCREASING INCIDENCE OF PREVENTABLE CHRONIC DISEASES: A MAJOR MARKET DRIVER 46
TABLE 2 LACK OF AWARENESS AND ACCESS TO DIGITAL THERAPEUTICS PROGRAMS IN DEVELOPING COUNTRIES: A MAJOR RESTRAINT FOR MARKET GROWTH 48
TABLE 3 EMERGING MARKETS OFFER SIGNIFICANT GROWTH OPPORTUNITIES 49
TABLE 4 STRINGENT REGULATORY GUIDELINES: A MAJOR CHALLENGE FOR MARKET GROWTH 51
TABLE 5 LIST OF VENTURE CAPITAL INVESTMENTS IN THE DIGITAL THERAPEUTICS MARKET (2007-2016) 56
TABLE 6 LIST OF PIPELINE PRODUCTS IN THE MARKET (2015-2021) 58
TABLE 7 DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
2014-2021 (USD MILLION) 62
TABLE 8 DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
BY BUYER, 2014-2021 (USD MILLION) 63
TABLE 9 DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
BY REGION, 2014-2021 (USD MILLION) 63
TABLE 10 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY COUNTRY, 2014-2021 (USD MILLION) 63
TABLE 11 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
BY COUNTRY, 2014-2021 (USD THOUSAND) 64
TABLE 12 DIGITAL THERAPEUTICS MARKET SIZE FOR CAREGIVERS, BY REGION,
2014-2021 (USD MILLION) 65
TABLE 13 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR CAREGIVERS,
BY COUNTRY, 2014-2021 (USD MILLION) 65
TABLE 14 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR CAREGIVERS,
BY COUNTRY, 2014-2021 (USD THOUSAND) 66
TABLE 15 DIGITAL THERAPEUTICS MARKET SIZE FOR PATIENTS, BY REGION,
2014-2021 (USD THOUSAND) 67
TABLE 16 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PATIENTS,
BY COUNTRY, 2014-2021 (USD MILLION) 67
TABLE 17 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PATIENTS,
BY COUNTRY, 2014-2021 (USD THOUSAND) 68
TABLE 18 DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
BY BUYER, 2014-2021 (USD MILLION) 70
TABLE 19 DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
BY REGION, 2014-2021 (USD MILLION) 70
TABLE 20 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY COUNTRY, 2014-2021 (USD MILLION) 71
TABLE 21 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
BY COUNTRY, 2014-2021 (USD MILLION) 71
TABLE 22 DIGITAL THERAPEUTICS MARKET SIZE FOR PROVIDERS, BY REGION,
2014-2021 (USD MILLION) 72
TABLE 23 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PROVIDERS,
BY COUNTRY, 2014-2021 (USD MILLION) 73
TABLE 24 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PROVIDERS,
BY COUNTRY, 2014-2021 (USD THOUSAND) 73
TABLE 25 DIGITAL THERAPEUTICS MARKET SIZE FOR PAYERS, BY REGION,
2014-2021 (USD MILLION) 74
TABLE 26 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PAYERS,
BY COUNTRY, 2014-2021 (USD MILLION) 75
TABLE 27 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PAYERS, BY COUNTRY,
2014-2021 (USD MILLION) 75
TABLE 28 DIGITAL THERAPEUTICS MARKET SIZE FOR PHARMACEUTICAL COMPANIES,
BY REGION, 2014-2021 (USD THOUSAND) 76
TABLE 29 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION) 76
TABLE 30 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014-2021 (USD THOUSAND) 77
TABLE 31 DIGITAL THERAPEUTICS MARKET SIZE FOR EMPLOYERS, BY REGION,
2014-2021 (USD MILLION) 78
TABLE 32 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR EMPLOYERS,
BY COUNTRY, 2014-2021 (USD MILLION) 78
TABLE 33 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR EMPLOYERS, BY COUNTRY, 2014-2021 (USD THOUSAND) 79
TABLE 34 DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER BUYERS, BY REGION,
2014-2021 (USD THOUSAND) 79
TABLE 35 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER BUYERS,
BY COUNTRY, 2014-2021 (USD THOUSAND) 80
TABLE 36 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER BUYERS,
BY COUNTRY, 2014-2021 (USD THOUSAND) 80
TABLE 37 DIGITAL THERAPEUTICS MARKET SIZE, BY TYPE OF APPLICATION,
2014–2021 (USD MILLION) 83
TABLE 39 DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
2014–2021 (USD MILLION) 85
TABLE 40 DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
BY REGION, 2014–2021 (USD MILLION) 85
TABLE 41 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 86
TABLE 42 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 86
TABLE 43 DIGITAL THERAPEUTICS MARKET SIZE FOR PREDIABETES, BY REGION,
2014–2021 (USD MILLION) 87
TABLE 44 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PREDIABETES,
BY COUNTRY, 2014–2021 (USD MILLION) 88
TABLE 45 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREDIABETES,
BY COUNTRY, 2014–2021 (USD THOUSAND) 88
TABLE 46 DIGITAL THERAPEUTICS MARKET SIZE FOR OBESITY, BY REGION,
2014–2021 (USD MILLION) 89
TABLE 47 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR OBESITY,
BY COUNTRY, 2014–2021 (USD MILLION) 90
TABLE 48 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR OBESITY,
BY COUNTRY, 2014–2021 (USD MILLION) 90
TABLE 49 DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-RELATED APPLICATIONS, 2014–2021 (USD MILLION) 92
TABLE 50 DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2014–2021 (USD MILLION) 92
TABLE 51 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-RELATED APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 93
TABLE 52 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-RELATED APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 93
TABLE 53 DIGITAL THERAPEUTICS MARKET SIZE FOR DIABETES, BY REGION,
2014–2021 (USD MILLION) 94
TABLE 54 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR DIABETES,
BY COUNTRY, 2014–2021 (USD MILLION) 95
TABLE 55 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR DIABETES, BY COUNTRY, 2014–2021 (USD MILLION) 95
TABLE 56 DIGITAL THERAPEUTICS MARKET SIZE FOR CNS DISORDERS, BY REGION,
2014–2021 (USD THOUSAND) 96
TABLE 57 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR CNS DISORDERS,
BY COUNTRY, 2014–2021 (USD MILLION) 97
TABLE 58 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR CNS DISORDERS,
BY COUNTRY, 2014–2021 (USD THOUSAND) 97
TABLE 59 DIGITAL THERAPEUTICS MARKET SIZE FOR CHRONIC RESPIRATORY DISEASES,
BY REGION, 2014–2021 (USD THOUSAND) 98
TABLE 60 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR CHRONIC RESPIRATORY DISEASES, BY COUNTRY, 2014–2021 (USD MILLION) 99
TABLE 61 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR CHRONIC RESPIRATORY DISEASES, BY COUNTRY, 2014–2021 (USD THOUSAND) 99
TABLE 62 DIGITAL THERAPEUTICS MARKET SIZE FOR MUSCULOSKELETAL DISORDERS,
BY REGION, 2014–2021 (USD THOUSAND) 100
TABLE 63 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2014–2021 (USD MILLION) 101
TABLE 64 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2014–2021 (USD THOUSAND) 101
TABLE 65 DIGITAL THERAPEUTICS MARKET SIZE FOR CARDIOVASCULAR DISEASES,
BY REGION, 2014–2021 (USD MILLION) 102
TABLE 66 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2014–2021 (USD MILLION) 103
TABLE 67 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2014–2021 (USD THOUSAND) 103
TABLE 68 DIGITAL THERAPEUTICS MARKET SIZE FOR SMOKING CESSATION, BY REGION, 2014–2021 (USD MILLION) 104
TABLE 69 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR SMOKING CESSATION, BY COUNTRY, 2014–2021 (USD MILLION) 105
TABLE 70 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR SMOKING CESSATION,
BY COUNTRY, 2014–2021 (USD MILLION) 105
TABLE 71 DIGITAL THERAPEUTICS MARKET SIZE FOR MEDICATION ADHERENCE, BY REGION, 2014–2021 (USD THOUSAND) 106
TABLE 72 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR MEDICATION ADHERENCE, BY COUNTRY, 2014–2021 (USD MILLION) 107
TABLE 73 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR MEDICATION ADHERENCE,
BY COUNTRY, 2014–2021 (USD THOUSAND) 107
TABLE 74 DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER APPLICATIONS,
BY REGION, 2014–2021 (USD THOUSAND) 108
TABLE 75 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 108
TABLE 76 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER APPLICATIONS,
BY COUNTRY, 2014–2021 (USD THOUSAND) 109
TABLE 77 DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 112
TABLE 78 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 115
TABLE 79 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 115
TABLE 80 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014–2021 (USD MILLION) 115
TABLE 81 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD MILLION) 116
TABLE 82 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2014-2021 (USD MILLION) 116
TABLE 83 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION) 117
TABLE 84 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION) 117
TABLE 85 U.S.: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 119
TABLE 86 U.S.: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
BY DISORDER, 2014–2021 (USD MILLION) 119
TABLE 87 U.S.: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD MILLION) 120
TABLE 88 U.S.: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
2014-2021 (USD MILLION) 120
TABLE 89 U.S.: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
BY BUYER, 2014-2021 (USD MILLION) 121
TABLE 90 U.S.: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
BY BUYER, 2014-2021 (USD MILLION) 121
TABLE 91 CANADA: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 122
TABLE 92 CANADA: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014–2021 (USD MILLION) 123
TABLE 93 CANADA: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD MILLION) 123
TABLE 94 CANADA: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
2014-2021 (USD MILLION) 124
TABLE 95 CANADA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
BY BUYER, 2014-2021 (USD MILLION) 124
TABLE 96 CANADA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
BY BUYER, 2014-2021 (USD THOUSAND) 125
TABLE 97 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 127
TABLE 98 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 127
TABLE 99 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014–2021 (USD MILLION) 127
TABLE 100 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD MILLION) 128
TABLE 101 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
2014-2021 (USD MILLION) 128
TABLE 102 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
BY BUYER, 2014-2021 (USD MILLION) 129
TABLE 103 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
BY BUYER, 2014-2021 (USD MILLION) 129
TABLE 104 GERMANY: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 130
TABLE 105 GERMANY: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014–2021 (USD MILLION) 130
TABLE 106 DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD MILLION) 131
TABLE 107 GERMANY: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
2014-2021 (USD MILLION) 131
TABLE 108 GERMANY: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
BY BUYER, 2014-2021 (USD MILLION) 132
TABLE 109 GERMANY: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
BY BUYER, 2014-2021 (USD MILLION) 132
TABLE 110 U.K.: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 133
TABLE 111 U.K.: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
BY DISORDER, 2014–2021 (USD MILLION) 133
TABLE 112 U.K.: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD THOUSAND) 134
TABLE 113 U.K.: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
2014-2021 (USD MILLION) 134
TABLE 114 U.K.: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
BY BUYER, 2014-2021 (USD MILLION) 135
TABLE 115 U.K.: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
BY BUYER, 2014-2021 (USD THOUSAND) 135
TABLE 116 FRANCE: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 136
TABLE 117 FRANCE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014–2021 (USD MILLION) 136
TABLE 118 FRANCE: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD THOUSAND) 137
TABLE 119 FRANCE: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
2014-2021 (USD MILLION) 137
TABLE 120 FRANCE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
BY BUYER, 2014-2021 (USD MILLION) 138
TABLE 121 FRANCE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
BY BUYER, 2014-2021 (USD THOUSAND) 138
TABLE 122 SPAIN: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 139
TABLE 123 SPAIN: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
BY DISORDER, 2014–2021 (USD THOUSAND) 139
TABLE 124 SPAIN: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD THOUSAND) 140
TABLE 125 SPAIN: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
2014-2021 (USD THOUSAND) 140
TABLE 126 SPAIN: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
BY BUYER, 2014-2021 (USD THOUSAND) 141
TABLE 127 SPAIN: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
BY BUYER, 2014-2021 (USD THOUSAND) 141
TABLE 128 ROE: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 142
TABLE 129 ROE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
BY DISORDER, 2014–2021 (USD MILLION) 142
TABLE 130 ROE: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD THOUSAND) 143
TABLE 131 ROE: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
2014-2021 (USD THOUSAND) 143
TABLE 132 ROE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
BY BUYER, 2014-2021 (USD THOUSAND) 144
TABLE 133 ROE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
BY BUYER, 2014-2021 (USD THOUSAND) 144
TABLE 134 APAC: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 146
TABLE 135 APAC: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
BY DISORDER, 2014–2021 (USD MILLION) 146
TABLE 136 APAC: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD THOUSAND) 147
TABLE 137 APAC: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
2014-2021 (USD MILLION) 147
TABLE 138 APAC: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
BY BUYER, 2014-2021 (USD MILLION) 148
TABLE 139 APAC: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
BY BUYER, 2014-2021 (USD THOUSAND) 148
TABLE 140 ROW: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 149
TABLE 141 ROW: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
BY DISORDER, 2014–2021 (USD MILLION) 149
TABLE 142 ROW: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD THOUSAND) 150
TABLE 143 ROW: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
2014-2021 (USD MILLION) 150
TABLE 144 ROW: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
BY BUYER, 2014-2021 (USD THOUSAND) 151
TABLE 145 ROW: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
BY BUYER, 2014-2021 (USD THOUSAND) 151
TABLE 146 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS, 2016 156
TABLE 147 INVESTMENTS, 2015–2016 157
TABLE 148 NEW PRODUCT LAUNCHES, 2014–2016 158
TABLE 149 OTHER STRATEGIES, 2013–2016 159

* indicates required information

* indicates required information


Share this Product


More from this collection